partner with:

amyotrophic lateral sclerosis

number of breaks: 1

showing 1-1 of 1 breaks

Gene therapy and ALS: one step closer to the clinic

Amyotrophic lateral sclerosis (ALS) is a devastating disease that on average kills in only 3 to 5 years after diagnosis, and for which there is still no cure today. ALS patients have progressive muscle weakness, leading to gradual paralysis and difficulties breathing which will usually... click to read more

  • Florie Borel | Postdoctoral Research Fellow at Horae Gene Therapy Center, University of Massachusetts Medical School, USA
  • Christian Mueller | Associate Professor at Horae Gene Therapy Center; Department of Pediatrics, University of Massachusetts Medical School, USA
Views 4783
Reading time 4 min
published on Mar 6, 2019